Human studies using Lactobacillus as a probiotic have often demonstrated decreased body weight and/or body fat in a strain-dependent manner (for a review of human studies, see Crovesy et al., 2017 58 ), suggesting that the NNMTi-and-LD-mediated changes to Lactobacillus relative abundance may be critical to NNMTi-mediated weight loss
AOD-9604's mechanism is thought to involve the stimulation of lipolysis and the inhibition of lipogenesis (the formation of new fat), specifically by upregulating the beta-3 adrenergic receptors in adipose tissue
Gastrointestinal changes after bariatric surgery
Toxins, including benzene (a chemical sometimes used in manufacturing and chemical synthesis), pesticides, and arsenic Chemotherapy and radiation therapy for cancer treatment Various infectious diseases, including hepatitis, HIV, and Epstein-Barr virus (a type of herpesvirus) Autoimmune disorders such as lupus and rheumatoid arthritis Pregnancy Certain drugs, including some antibiotics, immunosuppressants, and some nonsteroidal anti-inflammatory drugs (NSAIDs) Fanconi anemia ShwachmanDiamond syndrome Ataxia-pancytopenia syndrome Over time, severe heart issues may develop, such as arrhythmia (irregular heartbeat), angina, enlarged heart, and heart failure
These conditions can cause B12 levels to rise as a secondary phenomenon
